ECM Substrates Biasing Neural Stem Cell Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for neural stem cell therapy to restore nerve function in gastrointestinal disorders lack effective methods to modulate neural stem cell differentiation and ensure phenotypic stability and long-term survival of transplanted cells, particularly in the context of enteric nervous system regeneration.
Innovation Solution
The use of extracellular matrix (ECM) compositions, such as collagen I, collagen IV, laminin, and heparan sulfate, to bias neural stem cell differentiation into specific neuronal subtypes and glial cells, with the ECM components being used in hydrogels or substrate coatings to guide differentiation and support the survival of transplanted cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If neural stem cells are transplanted to restore nerve function, then neuronal function can be reinstated, but phenotypic stability and long-term survival of transplanted cells cannot be ensured
Solution Approach 1:
The patent introduces extracellular matrix (ECM) components as intermediary substances that mediate between the transplanted neural stem cells and the host tissue environment. These ECM components create a supportive microenvironment that guides cell differentiation, maintains phenotypic stability, and enhances long-term survival of transplanted cells while enabling neuronal function restoration.
Solution Approach 2:
The patent modifies the physical and chemical parameters of the transplantation environment by incorporating specific ECM components with defined concentrations and compositions. These parameter changes in the microenvironment directly influence cell behavior, differentiation patterns, and survival rates, thereby ensuring both functional restoration and phenotypic stability.
2Reliability
If neural stem cells are transplanted to restore nerve function, then neuronal function can be reinstated, but long-term survival of transplanted cells cannot be ensured
Solution Approach 1:
The patent applies preliminary action by pre-preparing and incorporating extracellular matrix components into the transplantation scaffold before cell implantation. This preliminary configuration of the microenvironment ensures immediate cellular support upon transplantation, promoting cell attachment, survival, and long-term persistence while enabling functional restoration.
Solution Approach 2:
ECM components serve as intermediary substances that facilitate long-term cell survival by mediating interactions between transplanted neural stem cells and the host tissue. These intermediaries provide essential structural support, biochemical signals, and protective functions that extend the duration of cell viability and function.
3Manufacturing precision
If extracellular matrix components are used to bias neural stem cell differentiation, then specific neuronal subtypes can be enriched, but the complexity of the differentiation control system increases
Solution Approach 1:
The patent applies local quality by incorporating specific ECM components at defined locations and concentrations within the transplantation scaffold. Different regions of the scaffold can contain different ECM compositions tailored to guide differentiation toward specific neuronal subtypes, achieving precise differentiation control through localized material properties rather than system-wide complexity.
Data Source
AI summary
Differentiation and stability of neural stem cells can be enhanced by in vitro or in vivo culturing with one or more extracellular matrix (ECM) compositions, such as collagen I, IV, laminin and/or a heparan sulfate proteoglycan. In one aspect of the invention, adult mammalian enteric neuronal progenitor cells can be induced to differentiate on various substrates derived from components or combinations of neural ECM compositions. Collagen I and IV supported neuronal differentiation and extensive glial differentiation individually and in combination. Addition of laminin or heparan sulfate to collagen substrates unexpectedly improved neuronal differentiation, increasing neuron number, branching of neuronal processes, and initiation of neuronal network formation. In another aspect, neuronal subtype differentiation was affected by varying ECM compositions in hydrogels overlaid on intestinal smooth muscle sheets. The matrix compositions of the present invention can be used to tissue engineer transplantable innervated GI smooth muscle constructs to remedy aganglionic disorders.